These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25127306)

  • 1. In vivo X-ray imaging reveals improved airway surface hydration after a therapy designed for cystic fibrosis.
    Morgan KS; Donnelley M; Farrow N; Fouras A; Yagi N; Suzuki Y; Takeuchi A; Uesugi K; Boucher RC; Siu KK; Parsons DW
    Am J Respir Crit Care Med; 2014 Aug; 190(4):469-71. PubMed ID: 25127306
    [No Abstract]   [Full Text] [Related]  

  • 2. SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.
    Scott DW; Walker MP; Sesma J; Wu B; Stuhlmiller TJ; Sabater JR; Abraham WM; Crowder TM; Christensen DJ; Tarran R
    Am J Respir Crit Care Med; 2017 Sep; 196(6):734-744. PubMed ID: 28481660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pulmonary therapies directed at targets other than CFTR.
    Donaldson SH; Galietta L
    Cold Spring Harb Perspect Med; 2013 Jun; 3(6):. PubMed ID: 23732851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art.
    Althaus M
    Curr Mol Pharmacol; 2013 Mar; 6(1):3-12. PubMed ID: 23547930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis Airways.
    Reihill JA; Walker B; Hamilton RA; Ferguson TE; Elborn JS; Stutts MJ; Harvey BJ; Saint-Criq V; Hendrick SM; Martin SL
    Am J Respir Crit Care Med; 2016 Sep; 194(6):701-10. PubMed ID: 27014936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENaC inhibitors for the treatment of cystic fibrosis.
    Butler R; Hunt T; Smith NJ
    Pharm Pat Anal; 2015 Jan; 4(1):17-27. PubMed ID: 25565157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis - a patent evaluation.
    Schoenberger M; Althaus M
    Expert Opin Ther Pat; 2013 Oct; 23(10):1383-9. PubMed ID: 23957246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic Fibrosis.
    Bennett WD; Henderson AG; Donaldson SH
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S186-90. PubMed ID: 27115955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.
    Mall MA; Mayer-Hamblett N; Rowe SM
    Am J Respir Crit Care Med; 2020 May; 201(10):1193-1208. PubMed ID: 31860331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea.
    Wills PJ; Hall RL; Chan W; Cole PJ
    J Clin Invest; 1997 Jan; 99(1):9-13. PubMed ID: 9011581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
    Middleton PG; Geddes DM; Alton EW
    Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial Na
    Smith NJ; Solovay CF
    Pharm Pat Anal; 2017 Jul; 6(4):179-188. PubMed ID: 28696180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Ringer-Lactate and isotonic saline solutions on mucociliary clearance of tracheal epithelium: an experimental study in rats.
    Unal M; Seymen HO
    J Laryngol Otol; 2002 Jul; 116(7):536-8. PubMed ID: 12238674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
    N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENaC-mediated effects assessed by MRI in a rat model of hypertonic saline-induced lung hydration.
    Blé FX; Cannet C; Collingwood S; Danahay H; Beckmann N
    Br J Pharmacol; 2010 Jun; 160(4):1008-15. PubMed ID: 20590595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.
    Danahay HL; Lilley S; Fox R; Charlton H; Sabater J; Button B; McCarthy C; Collingwood SP; Gosling M
    Am J Respir Crit Care Med; 2020 Apr; 201(8):946-954. PubMed ID: 31898911
    [No Abstract]   [Full Text] [Related]  

  • 17. Live-pig-airway surface imaging and whole-pig CT at the Australian Synchrotron Imaging and Medical Beamline.
    Donnelley M; Morgan KS; Gradl R; Klein M; Hausermann D; Hall C; Maksimenko A; Parsons DW
    J Synchrotron Radiat; 2019 Jan; 26(Pt 1):175-183. PubMed ID: 30655483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Therapy of Bicarbonate, Glutathione, and Ascorbic Acid Improves Cystic Fibrosis Mucus Transport.
    Adewale AT; Falk Libby E; Fu L; Lenzie A; Boitet ER; Birket SE; Petty CF; Johns JD; Mazur M; Tearney GJ; Copeland D; Durham C; Rowe SM
    Am J Respir Cell Mol Biol; 2020 Sep; 63(3):362-373. PubMed ID: 32374624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution mucociliary transport measurement in live excised large animal trachea using synchrotron X-ray imaging.
    Donnelley M; Morgan KS; Awadalla M; Farrow NR; Hall C; Parsons DW
    Respir Res; 2017 May; 18(1):95. PubMed ID: 28511651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
    Tiddens HA; Donaldson SH; Rosenfeld M; Paré PD
    Pediatr Pulmonol; 2010 Feb; 45(2):107-17. PubMed ID: 20082341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.